Evidence map›Paper›PMID 31703077›Full record

ArticlePloS one2019

The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer.

Kenji Kuroda, Masakazu Yashiro, Tomohiro Sera, Yurie Yamamoto, Yukako Kushitani, Atsushi Sugimoto, Syuhei Kushiyama, Sadaaki Nishimura, Shingo Togano, Tomohisa Okuno and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pathophysiological roles of thrombospondin-4 in disease development.Seminars in cell & developmental biology · 2024
    Review
  7. Review
  8. Lipocalin-2 negatively regulates epithelial-mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  9. Extracellular Matrix Biomarkers in Colorectal Cancer.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Kenji KurodaDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Masakazu YashiroDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.ORCID 0000-0001-5743-7228
Tomohiro SeraDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Yurie YamamotoMolecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Yukako KushitaniDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Atsushi SugimotoDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Syuhei KushiyamaDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Sadaaki NishimuraDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Shingo ToganoDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Tomohisa OkunoDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Tatsuro TamuraDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Takahiro ToyokawaDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Hiroaki TanakaDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Kazuya MugurumaDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Masaichi OhiraDepartment of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka city, Japan.
Osaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThrombospondin-4 [1] is an extracellular glycoprotein involved in wound healing and tissue remodeling. Although THBS4 is reportedly frequently expressed in solid tumors, there are few reports of the clinicopathological features of carcinomas with THBS4 expression. We evaluated the clinicopathologic significance of THBS4 expression in gastric carcinoma (GC). MATERIALS AND

methodsWe retrospectively analyzed the cases of 584 GC patients. The expression of THBS4 in each tumor was evaluated by immunohistochemistry. We then divided the patients into the THBS4-high (n = 223, 38.2%) group and THBS4-low (n = 361, 61.8%) group. THBS4 expression in cancer-associated fibroblasts (CAFs), normal-associated fibroblasts (NFs) and gastric cancer cell lines was examined by western blotting.

resultsTHBS4 is expressed on stromal cells with αSMA or Podoplanin expression in the GC microenvironment, but not expressed on cancer cells with cytokeratin expression. The western blot analysis results showed that CAFs (but not NFs and cancer cells) expressed THBS4. Compared to the THBS4-low expression status, the THBS4-high expression status was correlated with higher αSMA expression, higher invasion depth, lymph-node metastasis, lymphatic invasion, peritoneal cytology, peritoneal metastasis, larger tumor size, microscopic diffuse type, and the macroscopic diffuse infiltrating type. The THBS4-high group's 5-year overall survival rate was significantly poorer than that of the THBS4-low group. A multivariate analysis revealed that THBS4 expression was an independent prognostic factor.

conclusionTHBS4 is expressed on CAFs in the gastric cancer microenvironment. THBS4 from CAFs is associated with the metastasis of cancer cells, and is a useful prognostic indicator for gastric cancer patients.

Indexed as

Tumor MicroenvironmentCancer-Associated FibroblastsCell Line, TumorHumansMembrane GlycoproteinsMultivariate AnalysisPodoplaninStomach NeoplasmsStromal CellsSurvival AnalysisThrombospondinsMembrane GlycoproteinsPDPN protein, humanPodoplaninthrombospondin 4Thrombospondins

Identifiers

PMID31703077
PMCPMC6839882
OpenAlexW2983533943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.